PTEN and prostate neoplasm: In a recent study, phospho-PRAS40Thr246 expression was positively correlated with PI3K pathway activation and predicted PI3K pathway inhibitor sensitivity in triple-negative breast tumor tissues and a PTEN-deficient mouse prostate tumor model (7).